TCL Archive Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint March 29, 2013
TCL Archive “NIH Reveres, Honors, respects And Defends One And Only One Mechanisms’ – R01s September 20, 1991